Medical Condition News

RSS

Survey: 54% of men opt for prostate cancer screening test despite risks

A survey of men age 40 to 74 found that 54 percent said that they would still opt for a popular prostate cancer screening test despite recent recommendations that the test not be performed, finds a new study in American Journal of Preventive Medicine. Only 13 percent said they would choose not to be tested.

9 Jul 2013

MerTK inhibition in leukocytes decreases tumor growth and metastasiss

The tyrosine kinase MerTK plays a prominent role in the body's immune response. MerTK signaling helps "calm" the body's first line of immunity, the macrophage, while it performs the routine duties - clearing cells that die and healing damaged tissue.

9 Jul 2013

Study shows very few physicians follow HPV and cervical cancer prevention guidelines

Recent breakthroughs in cervical cancer prevention have resulted in new vaccination and cervical cancer screening guidelines. Recommendations do not always translate into practice, however.

9 Jul 2013

University of Pennsylvania resident receives inaugural Dr. Mark G. Lebwohl Medical Dermatology Fellowship

The National Psoriasis Foundation awarded Zelma Chiesa Fuxench, M.D., of the University of Pennsylvania, its inaugural Dr. Mark G. Lebwohl Medical Dermatology Fellowship, recognizing her work as a promising psoriasis and psoriatic arthritis researcher.

9 Jul 2013

Multimodal neuroimaging approach helps study structural and functional abnormalities in brain

Major depressive disorder is associated with a dysregulation of brain regions including the prefrontal cortex and limbic system. The relationship between structural and functional abnormalities in these brain regions in depressed patients is far from clear. However, both types of changes are assumed to underlie the symptoms of this disorder.

9 Jul 2013

Early signs of Alzheimer's disease can be detected years before diagnosis, say researchers

Early signs of Alzheimer's disease can be detected years before diagnosis, according to researchers at Birmingham City University. The study found that sufferers of a specific type of cognitive impairment have an increased loss of cells in certain parts of the brain, which can be vital in detecting which patients will progress to a diagnosis of Alzheimer's.

9 Jul 2013

Research shows hydrogen sulfide is a key player in colon cancer metabolism

University of Texas Medical Branch at Galveston researchers have discovered that hydrogen sulfide - the pungent-smelling gas produced by rotten eggs - is a key player in colon cancer metabolism, and a potential target for therapies for the disease.

9 Jul 2013

Drugs used to control BP associated with lower risk of heart failure in diabetic patients

Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published in CMAJ (Canadian Medical Association Journal).

9 Jul 2013

Mouse study identifies new treatment options for bowel cancer

Researchers have discovered the genetic processes that cause specific types of bowel cancer. Using this knowledge, they identified cancer drugs that target these genes. Their findings offer the opportunity to develop personalised treatment based on a person's genetic profile.

9 Jul 2013

Soy peptide injection dramatically reduces colon cancer metastasis in mice

After a recent University of Illinois study showed that injection of the soy peptide lunasin dramatically reduced colon cancer metastasis in mice, the researchers were eager to see how making lunasin part of the animals' daily diet would affect the spread of the disease.

9 Jul 2013

Anti-cancer compounds offer hope for treating breast cancer

Melbourne researchers have discovered that anti-cancer compounds currently in clinical trials for some types of leukaemia could offer hope for treating the most common type of breast cancer.

9 Jul 2013

CPAP reduces nightmare frequency, motivates treatment compliance in patients with PTSD and OSA

A new study suggests that CPAP therapy reduces nightmares in veterans with post-traumatic stress disorder (PTSD) and obstructive sleep apnea (OSA).

9 Jul 2013

Penumbra announces launch of 5MAX ACE device for acute ischemic stroke treatment

Today, Penumbra, Inc. announced the launch and wide availability of the 5MAX ACE, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots causing an acute ischemic stroke.

8 Jul 2013

Spanish doctors perform more than 1,500 POSE weight loss procedures

Spanish doctors are leading the way by performing more than 1,500 procedures of the scar-free, non invasive, weight loss method of Primary Obesity Surgery, Endolumenal, known as POSE. Over thirty Spanish doctors have now performed more cases in Spain (where 1 in 6 people are obese) than in any other part of the world.

8 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, announced today the publication of pre-clinical data for VB-201 in the journal of Atherosclerosis.

8 Jul 2013

First Edition: July 8, 2013

Today's early morning highlights from the major news organizations, including news about a new ad campaign against the health law, more reaction to the administration's delay of the employer mandate provision and states efforts to restrict abortions.

8 Jul 2013

HeadSense closes financing for non-invasive intracranial pressure monitor

HeadSense, an early stage company developing a non-invasive neurological monitor focused initially on an intracranial pressure application, today announced it closed financing led by Pontifax, a leading Israeli VC; GE Ventures of Menlo Park, California, USA; Everett Partners, an investment group based out of Akron, Ohio, USA; and JuMaJo, an investment group from Hamburg, Germany.

8 Jul 2013

AIFA grants market access for CTI's PIXUVRI to treat patients with aggressive B-cell NHL

Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).

8 Jul 2013

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Probiodrug AG (Probiodrug) announced that it will be making two poster and two oral presentations at the upcoming Alzheimer's Association International Conference in Boston, MA July 13 - 18, 2013.

8 Jul 2013

Medical Condition News

Survey: 54% of men opt for prostate cancer screening test despite risks

MerTK inhibition in leukocytes decreases tumor growth and metastasiss

Study shows very few physicians follow HPV and cervical cancer prevention guidelines

University of Pennsylvania resident receives inaugural Dr. Mark G. Lebwohl Medical Dermatology Fellowship

Multimodal neuroimaging approach helps study structural and functional abnormalities in brain

Early signs of Alzheimer's disease can be detected years before diagnosis, say researchers

Research shows hydrogen sulfide is a key player in colon cancer metabolism

Drugs used to control BP associated with lower risk of heart failure in diabetic patients

Mouse study identifies new treatment options for bowel cancer

Soy peptide injection dramatically reduces colon cancer metastasis in mice

Anti-cancer compounds offer hope for treating breast cancer

CPAP reduces nightmare frequency, motivates treatment compliance in patients with PTSD and OSA

Penumbra announces launch of 5MAX ACE device for acute ischemic stroke treatment

Spanish doctors perform more than 1,500 POSE weight loss procedures

Soligenix announces personalized medicine collaboration with SciClone

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

First Edition: July 8, 2013

HeadSense closes financing for non-invasive intracranial pressure monitor

AIFA grants market access for CTI's PIXUVRI to treat patients with aggressive B-cell NHL

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News